| Not Yet Recruiting | Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Adva NCT07314203 | Fujian Medical University | Phase 3 |
| Not Yet Recruiting | Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metast NCT06093425 | Suzhou Transcenta Therapeutics Co., Ltd. | Phase 3 |
| Not Yet Recruiting | Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer NCT07101666 | Washington University School of Medicine | Phase 2 |
| Not Yet Recruiting | Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma NCT07529808 | BigHat Biosciences, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | 18F-FAPI PET/CT and MRI in Gastric Cancer NCT07510867 | First Affiliated Hospital of Zhejiang University | — |
| Recruiting | AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer NCT07525765 | First Affiliated Hospital of Zhejiang University | — |
| Not Yet Recruiting | RCT Comparing Reduced-port Robotic and Conventional Laparoscopic Subtotal Gastrectomy NCT07467174 | Yonsei University | Phase 4 |
| Recruiting | Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Canc NCT07464470 | Blokhin's Russian Cancer Research Center | — |
| Not Yet Recruiting | Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinom NCT07507916 | Fudan University | Phase 2 |
| Recruiting | Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors NCT07517198 | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | Phase 1 |
| Not Yet Recruiting | A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN) NCT07518147 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 3 |
| Not Yet Recruiting | Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer NCT07511894 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Recruiting | [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications NCT07432633 | Blue Earth Diagnostics | Phase 1 / Phase 2 |
| Not Yet Recruiting | Application of Indocyanine Green Tracer in D2 Lymphadenectomy of Locally Advanced Gastric Cancer NCT06892392 | Hospital of Navarra | N/A |
| Not Yet Recruiting | Comparison of the Postoperative Analgesic Effects of the Temperature-responsive Gel Mixed With Local Anestheti NCT07452471 | Gyeong-Jo Byeon, MD, PhD | N/A |
| Recruiting | Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanc NCT07431281 | AstraZeneca | Phase 3 |
| Not Yet Recruiting | Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma NCT07374250 | Sichuan University | Phase 2 |
| Recruiting | Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy NCT07441850 | Beijing Friendship Hospital | N/A |
| Active Not Recruiting | Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer NCT07448493 | Blokhin's Russian Cancer Research Center | — |
| Active Not Recruiting | Surgery for Obstructed Gastric Carcinoma NCT07435025 | Zagazig University | N/A |
| Recruiting | Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer NCT07432295 | I-Mab Biopharma US Limited | Phase 2 |
| Not Yet Recruiting | MRinRT: Swansea University and SWWCC Collaboration Study. NCT07365124 | Swansea Bay University Health Board | — |
| Recruiting | Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer NCT07517107 | Fudan University | Phase 2 |
| Not Yet Recruiting | Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy NCT07351474 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Recruiting | Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gas NCT07537361 | Qilu Hospital of Shandong University | Phase 2 |
| Not Yet Recruiting | Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue NCT07276854 | Nanfang Hospital, Southern Medical University | — |
| Recruiting | Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarci NCT07277439 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Recruiting | Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas NCT06346197 | Centre Leon Berard | Phase 3 |
| Not Yet Recruiting | Minimal Residual Disease in Solid Malignancies NCT07268469 | European Institute of Oncology | N/A |
| Enrolling By Invitation | A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid T NCT07218003 | Rondo Therapeutics | Phase 1 |
| Recruiting | Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignan NCT07149090 | Asan Medical Center | Phase 1 / Phase 2 |
| Recruiting | A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer NCT07227168 | Sutro Biopharma, Inc. | Phase 1 |
| Recruiting | Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia NCT07359586 | Zhejiang University | — |
| Recruiting | Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment NCT07139366 | Yongquan Shi | Phase 4 |
| Recruiting | Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy NCT07175155 | Zhejiang University | N/A |
| Enrolling By Invitation | Eucine-Restricted Diet in Gastric Cancer Patients NCT07488312 | Qilu Hospital of Shandong University | Phase 1 |
| Recruiting | CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors NCT07179692 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Wi NCT04107077 | University of Chicago | Phase 2 |
| Recruiting | 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) NCT07124351 | Cedars-Sinai Medical Center | Phase 4 |
| Recruiting | Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer NCT07194005 | Fudan University | Phase 2 |
| Recruiting | Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors NCT07301814 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Recruiting | Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenoca NCT07389876 | Fudan University | — |
| Not Yet Recruiting | The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel NCT07139587 | Qingxia Li | N/A |
| Active Not Recruiting | A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastati NCT07143604 | AstraZeneca | Phase 2 |
| Recruiting | A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ C NCT07110571 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 2 |
| Recruiting | IDOV-Immune for Advanced Solid Tumors NCT06910657 | ViroMissile, Inc. | Phase 1 |
| Recruiting | Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors NCT07151040 | One-carbon Therapeutics AB | Phase 1 / Phase 2 |
| Not Yet Recruiting | Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer NCT07085273 | The First Affiliated Hospital of Zhengzhou University | Phase 2 |
| Recruiting | Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Alge NCT07481110 | Société Algérienne de Formation et Recherche en Oncologie | — |
| Recruiting | 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer NCT06298916 | Lantheus Medical Imaging | Phase 1 / Phase 2 |
| Recruiting | Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric NCT06768463 | University Medical Center Ho Chi Minh City (UMC) | N/A |
| Not Yet Recruiting | Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery NCT07098949 | Guangzhou University of Traditional Chinese Medicine | N/A |
| Recruiting | A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors NCT07066657 | ArriVent BioPharma, Inc. | Phase 1 |
| Recruiting | Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors NCT06974110 | MOMA Therapeutics | Phase 1 |
| Recruiting | Novel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early G NCT07294638 | Nanfang Hospital, Southern Medical University | — |
| Recruiting | [18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer NCT07018661 | Leiden University Medical Center | Phase 2 / Phase 3 |
| Recruiting | A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening NCT07032961 | Nanfang Hospital, Southern Medical University | — |
| Recruiting | Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric C NCT07076979 | Shanghai Minimally Invasive Surgery Center | — |
| Not Yet Recruiting | Artificial Intelligence to Solve the MissINg of Gastric Cancer (AIMING) NCT06971471 | Istituto Clinico Humanitas | N/A |
| Not Yet Recruiting | Proteomic Analysis of Patients Undergoing Bariatric Surgery NCT06787807 | Universidade Federal de Pernambuco | N/A |
| Recruiting | Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomize NCT06793917 | Fujian Cancer Hospital | Phase 3 |
| Recruiting | A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas NCT06999187 | Dren Bio | Phase 1 |
| Completed | Establishment and Effectiveness Evaluation of a Training System for Confocal Laser Endomicroscopy NCT06981819 | Changhai Hospital | — |
| Recruiting | IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer NCT07025889 | Ruijin Hospital | Phase 1 / Phase 2 |
| Not Yet Recruiting | The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer NCT06977386 | Yunnan Cancer Hospital | N/A |
| Active Not Recruiting | Reconstruction With a Lawrence-Hunt Jejunal Pouch After Total Gastrectomy NCT06967571 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Not Yet Recruiting | Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Pa NCT06414122 | University of Cologne | N/A |
| Recruiting | Clinical Evaluation of GRAPE Model for Gastric Cancer Screening NCT07067983 | Zhejiang Cancer Hospital | — |
| Recruiting | Identification of Biomarkers of Risk for Pre-neoplastic and Neoplastic Lesions for the Development of Gastric NCT07374731 | Centro di Riferimento Oncologico - Aviano | — |
| Not Yet Recruiting | Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer NCT06759233 | Zhongguang Luo, MD | Phase 2 |
| Recruiting | Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol) NCT06668454 | University Health Network, Toronto | N/A |
| Recruiting | Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors NCT07001592 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Phase 1 |
| Not Yet Recruiting | A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy NCT06957977 | Zhongguang Luo, MD | Phase 2 |
| Not Yet Recruiting | Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Su NCT06881017 | China Medical University, China | Phase 2 |
| Recruiting | Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy NCT06945718 | Fujian Medical University | — |
| Recruiting | Study for AZD4360 in Participants With Advanced Solid Tumours NCT06921928 | AstraZeneca | Phase 1 / Phase 2 |
| Recruiting | Lead-212 PSV359 Therapy for Patients With Solid Tumors NCT06710756 | Perspective Therapeutics | Phase 1 / Phase 2 |
| Recruiting | A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521 | Tanabe Pharma America, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy NCT06942663 | Nizhny Novgorod Regional Clinical Oncology Center | Phase 2 |
| Recruiting | COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patien NCT06796764 | Zhejiang University | N/A |
| Active Not Recruiting | Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors NCT06714617 | SystImmune Inc. | Phase 1 |
| Active Not Recruiting | ctDNA-MRD Monitoring After Resection in Gastric Cancer NCT06893133 | Peking University | — |
| Recruiting | Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women NCT06904365 | Washington University School of Medicine | — |
| Not Yet Recruiting | A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer NCT06464601 | Wuhan University | — |
| Recruiting | Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer NCT06028737 | Ukrainian Society of Clinical Oncology | Phase 2 / Phase 3 |
| Recruiting | Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic NCT06926374 | Chinese University of Hong Kong | N/A |
| Recruiting | Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors NCT06940102 | Changchun GeneScience Pharmaceutical Co., Ltd. | — |
| Recruiting | Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or NCT06731478 | Daiichi Sankyo | Phase 3 |
| Recruiting | SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastat NCT06873659 | Qurgen Inc. | Phase 1 |
| Recruiting | Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients NCT06915389 | Qinghai Red Cross Hospital | — |
| Recruiting | A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined Wi NCT06685887 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Recruiting | Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibr NCT06782412 | KU Leuven | Phase 2 / Phase 3 |
| Completed | COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients NCT06804876 | Zhejiang University | Phase 2 |
| Completed | Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastroint NCT06812403 | Zhejiang University | Phase 2 |
| Recruiting | Comparison of Full Robotic Instrumentation and Assistant-Controlled Laparoscopic Instrumentation in Robotic Di NCT06841484 | Gangnam Severance Hospital | N/A |
| Recruiting | Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscop NCT06839716 | Gangnam Severance Hospital | N/A |
| Recruiting | Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy NCT06778954 | Gangnam Severance Hospital | N/A |
| Recruiting | Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) NCT06710132 | EMD Serono Research & Development Institute, Inc. | Phase 1 / Phase 2 |
| Recruiting | Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers NCT07243015 | City of Hope Medical Center | — |
| Recruiting | Preventive Use of PIPAC in Locally Advanced Gastric Cancer. NCT06784765 | National Research Oncology and Transplantology Center, Kazakhstan | N/A |
| Recruiting | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors NCT06695845 | Jazz Pharmaceuticals | Phase 2 |
| Enrolling By Invitation | Differences in Gastric Microbiota in Patients Who Were Infected Between CagA Positive and Negative Helicobacte NCT06785922 | Mahidol University | N/A |
| Enrolling By Invitation | Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences( NCT06862479 | Unidade Local de Saúde Santa Maria | — |
| Enrolling By Invitation | Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients NCT06947096 | Qun Zhao | — |
| Recruiting | The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating L NCT07069842 | Changzhi People's Hospital Affiliated to Changzhi Medical College | — |
| Recruiting | Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer NCT06755554 | Ukrainian Society of Clinical Oncology | Phase 3 |
| Recruiting | Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch NCT07142122 | Fujian Cancer Hospital | N/A |
| Not Yet Recruiting | Preliminary Efficacy Analysis of "C" Single Flap Plasty Reconstruction After Laparoscopic Proximal Gastrectomy NCT06741501 | Daorong Wang | N/A |
| Recruiting | A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors NCT06783569 | JiaRay Group | Phase 1 |
| Recruiting | Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric NCT06308510 | Erasmus Medical Center | — |
| Recruiting | Efficacy of RUS GA Surgical Navigation for Robot-assisted Distal Gastrectomy in Gastric Cancer Patients NCT06639490 | Yonsei University | N/A |
| Recruiting | Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial NCT06580002 | University of California, Irvine | Phase 2 |
| Recruiting | Effect of Premedication With Pronase on Mucosal Cleanliness During EGD NCT06713421 | Changhai Hospital | N/A |
| Recruiting | Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Con NCT07056010 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Recruiting | The Effect of Different Digestive Tract Reconstruction Methods on Postoperative Quality of Life After Proximal NCT06929949 | The First Hospital of Jilin University | — |
| Recruiting | A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastro NCT06532006 | Shanghai Henlius Biotech | Phase 3 |
| Not Yet Recruiting | Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer NCT06697366 | Ruijin Hospital | Phase 2 |
| Recruiting | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations NCT06988475 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treat NCT06468280 | Shanghai Zhongshan Hospital | Phase 2 |
| Active Not Recruiting | Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2 NCT07224048 | University of Miami | Phase 4 |
| Not Yet Recruiting | Immunonutrition and Psychosocial Factors in the Recovery of Patients After Gastrectomy: a Multidimensional Ana NCT06578858 | Universidade Federal de Pernambuco | — |
| Recruiting | Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor NCT06826079 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 / Phase 3 |
| Not Yet Recruiting | A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss NCT06614751 | Danatlas Pharmaceuticals Co., Ltd | Phase 1 |
| Withdrawn | Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201 NCT06341647 | GC Cell Corporation | Phase 1 |
| Recruiting | Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery NCT07119463 | The First Hospital of Jilin University | Phase 2 |
| Recruiting | Avutometinib and Defactinib in Diffuse Gastric Cancer NCT06487221 | Ryan H. Moy, MD, PhD | Phase 2 |
| Not Yet Recruiting | The Efficacy and Safety of Benmelstobart for GC/EGC NCT06603974 | Xijing Hospital | N/A |
| Recruiting | Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors NCT06617169 | Monopar Therapeutics | Phase 1 |
| Recruiting | A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors NCT06586957 | NiKang Therapeutics, Inc. | Phase 1 |
| Recruiting | Energy CT in Imaging and Diagnosis of Gastric Cancer NCT06869694 | The First Affiliated Hospital of Zhengzhou University | — |
| Recruiting | Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanc NCT06560528 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Not Yet Recruiting | The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. NCT06295094 | Odense University Hospital | Phase 2 |
| Recruiting | How Epigenetic Changes in hMLH1 Connect Lab Research With Diagnosis in Gastric Cancer NCT06982768 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Active Not Recruiting | POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol After Gastric Surgery ( NCT06790238 | Grupo Español de Rehabilitación Multimodal | — |
| Recruiting | Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gast NCT06128252 | Tang-Du Hospital | N/A |
| Recruiting | HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes NCT06550063 | St. James's Hospital, Ireland | — |
| Completed | A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Ca NCT06585501 | Daiichi Sankyo | — |
| Not Yet Recruiting | Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor NCT06551896 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Recruiting | Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers NCT06580574 | Peking University | Phase 2 |
| Not Yet Recruiting | Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumo NCT06531291 | RenJi Hospital | Phase 2 |
| Recruiting | A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patien NCT06555471 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Recruiting | A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer NCT06776770 | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | Phase 1 / Phase 2 |
| Recruiting | Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer NCT06202105 | University Medical Center Ho Chi Minh City (UMC) | N/A |
| Recruiting | Molecular Assessment for Gastro-Esophageal Cancer NCT06346054 | KU Leuven | N/A |
| Not Yet Recruiting | Gastric Cancer Complicated With Bleeding NCT06522542 | Peking University Third Hospital | — |
| Not Yet Recruiting | Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Aden NCT06447636 | Fudan University | Phase 2 |
| Completed | Comparison of Textbook Outcomes Between Laparoscopic and Open Total Gastrectomy for Gastric Cancer NCT06758934 | Bakirkoy Dr. Sadi Konuk Research and Training Hospital | — |
| Not Yet Recruiting | Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China NCT06384300 | Peking University | N/A |
| Recruiting | Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal Gastrectomy NCT06475170 | Northern Jiangsu People's Hospital | N/A |
| Recruiting | Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment NCT06346080 | KU Leuven | N/A |
| Not Yet Recruiting | A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intrap NCT06496919 | Wuhan University | — |
| Not Yet Recruiting | Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer NCT06525714 | The First Hospital of Jilin University | EARLY_Phase 1 |
| Recruiting | A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours NCT06147037 | AstraZeneca | Phase 1 |
| Recruiting | A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointes NCT06500052 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | INSPIRE: a Multi-Cancer Early Detection Study NCT06440018 | Singlera Genomics Inc. | — |
| Not Yet Recruiting | Prospective Observational Cohort Study NCT06493448 | Lin Chen | — |
| Not Yet Recruiting | Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer NCT06499610 | First Affiliated Hospital Xi'an Jiaotong University | Phase 4 |
| Recruiting | Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced NCT06791148 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 2 |
| Completed | Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer NCT06464965 | Zhejiang Provincial People's Hospital | Phase 1 |
| Not Yet Recruiting | Enhanced vs. Routine Follow-Up After Total Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Tr NCT06468969 | Fudan University | N/A |
| Not Yet Recruiting | Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients NCT05498766 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 4 |
| Active Not Recruiting | Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 NCT06384417 | Milton S. Hershey Medical Center | N/A |
| Recruiting | Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer ( NCT06608381 | Gangnam Severance Hospital | Phase 3 |
| Recruiting | Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer NCT06306755 | Peking University Cancer Hospital & Institute | N/A |
| Recruiting | Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric NCT06791083 | First Affiliated Hospital of Fujian Medical University | Phase 2 |
| Recruiting | The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer wi NCT06597526 | Ruijin Hospital | — |
| Recruiting | Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroes NCT06461910 | Zekuan Xu | Phase 2 |
| Recruiting | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194 | ModeX Therapeutics, An OPKO Health Company | Phase 1 / Phase 2 |
| Not Yet Recruiting | GAIN Project: Gastric Cancer and Artificial Intelligence NCT06275997 | Istituto Clinico Humanitas | N/A |
| Not Yet Recruiting | Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer NCT06426654 | West China Hospital | Phase 1 / Phase 2 |
| Completed | Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After NCT06573307 | Chang-Ming Huang, Prof. | — |
| Recruiting | Personalised Health Recommendations to the General Population Through an Integrated AI Guided NCT06421324 | Fundación para la Investigación del Hospital Clínico de Valencia | N/A |
| Recruiting | Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and L NCT06157996 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Not Yet Recruiting | Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy NCT06419140 | Zhejiang Cancer Hospital | Phase 2 |
| Recruiting | Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatm NCT06521541 | The Affiliated Hospital of Qingdao University | N/A |
| Not Yet Recruiting | Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemo NCT06454435 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer NCT06405113 | Changzhou No.2 People's Hospital | Phase 2 |
| Recruiting | Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy NCT06464978 | Nanchong Central Hospital | N/A |
| Recruiting | Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors NCT06337084 | Monopar Therapeutics | Phase 1 |
| Not Yet Recruiting | Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer NCT06437678 | Zhejiang Cancer Hospital | Phase 2 |
| Recruiting | Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer NCT06475417 | Tang-Du Hospital | Phase 2 |
| Not Yet Recruiting | Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node D NCT06421220 | Qilu Hospital of Shandong University | N/A |
| Recruiting | A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Thera NCT06055439 | Chimeric Therapeutics | Phase 1 / Phase 2 |
| Recruiting | A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies NCT06395519 | 858 Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course N NCT06487429 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Active Not Recruiting | ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer NCT06489288 | Xijing Hospital | N/A |
| Completed | Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patien NCT06673472 | Chang-Ming Huang, Prof. | — |
| Recruiting | Myosteatosis in Oeso-gastric Cancer: Clinical Impacts NCT06419244 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Not Yet Recruiting | Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer NCT06349967 | West China Hospital | Phase 2 |
| Recruiting | Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Local NCT06385691 | Centre Leon Berard | Phase 2 |
| Not Yet Recruiting | Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment. NCT06374901 | Xiangdong Cheng | Phase 2 |
| Recruiting | Prediction Model of Occult Omental Metastasis in Patients With Gastric Cancer NCT06405009 | Northern Jiangsu People's Hospital | — |
| Recruiting | Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric Cancer NCT06105515 | Region Stockholm | N/A |
| Recruiting | First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer NCT06253611 | GERCOR - Multidisciplinary Oncology Cooperative Group | Phase 2 |
| Recruiting | Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Aden NCT06417892 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | — |
| Recruiting | A Study Collecting Health Information to Understand and Prevent Gastric Cancer NCT06370143 | Memorial Sloan Kettering Cancer Center | — |
| Unknown | Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer NCT06305169 | Sandwell & West Birmingham Hospitals NHS Trust | — |
| Not Yet Recruiting | Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC NCT06238167 | First Affiliated Hospital of Wenzhou Medical University | Phase 2 |
| Recruiting | Wecare Study in Gastric Cancer Survivors NCT06395935 | Gyeongsang National University Hospital | N/A |
| Recruiting | Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagoga NCT06383793 | Northern Jiangsu People's Hospital | — |
| Recruiting | Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM NCT06341595 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Not Yet Recruiting | Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore NCT06202716 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Not Yet Recruiting | Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application NCT06335576 | Shanghai Zhongshan Hospital | — |
| Recruiting | Microbiota and Metabolomics of Intestinal Type of Gastric Cancer NCT06079554 | Jilin University | — |
| Unknown | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis NCT06363123 | Beijing Friendship Hospital | — |
| Unknown | ONS in Gastric Cancer After Total Gastrectomy NCT05823272 | Jinling Hospital, China | N/A |
| Recruiting | Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic NCT06227728 | Gene Solutions | — |
| Active Not Recruiting | Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation NCT05899985 | Ferronova Pty Ltd | N/A |
| Not Yet Recruiting | A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer NCT06339216 | Chinese PLA General Hospital | Phase 2 |
| Unknown | Postoperative Morbidity and Mortality After Gastric Cancer Surgery NCT06277908 | P. Herzen Moscow Oncology Research Institute | — |
| Completed | Impact of TTC Following Neoadjuvant Chemotherapy on the Prognosis of LAGC NCT06696963 | Fujian Medical University | — |
| Recruiting | The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut NCT07400354 | Fudan University | — |
| Recruiting | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors NCT06257264 | BeiGene | Phase 1 |
| Recruiting | Metronomic Capecitabine in Stage III Gastric Cancer NCT06313567 | Fudan University | Phase 3 |
| Not Yet Recruiting | SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer NCT06266871 | West China Hospital | Phase 1 / Phase 2 |
| Recruiting | A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470 | MacroGenics | Phase 1 |
| Recruiting | AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or NCT06346392 | AstraZeneca | Phase 3 |
| Recruiting | H. Pylori Screen-and-treat Study in a Population of Young Adults NCT06275204 | University of Latvia | — |
| Not Yet Recruiting | Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Tri NCT06310473 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Recruiting | Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC NCT06371586 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual NCT06253650 | Gruppo Oncologico del Nord-Ovest | Phase 2 |
| Unknown | Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases NCT06224738 | First People's Hospital of Hangzhou | EARLY_Phase 1 |
| Completed | A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesoph NCT06452329 | Bristol-Myers Squibb | — |
| Recruiting | A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer NCT06296706 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 3 |
| Recruiting | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors NCT06172478 | Daiichi Sankyo | Phase 2 |
| Not Yet Recruiting | Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA NCT06222944 | Peking University | Phase 2 |
| Terminated | A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors NCT06264921 | NiKang Therapeutics, Inc. | Phase 1 |
| Recruiting | DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Ade NCT06221748 | RemeGen Co., Ltd. | Phase 2 / Phase 3 |
| Not Yet Recruiting | HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis NCT06213519 | Sichuan University | Phase 2 |
| Recruiting | Early Detection and Post-operative Monitoring of Gastric Cancer NCT06232395 | Suzhou Huhu Health & Technology Inc. | — |
| Recruiting | Post-operative Monitoring of Gastric Cancer NCT07026240 | Suzhou Huhu Health & Technology Inc. | — |
| Completed | Surveillance Endoscopy After Proximal Gastriectomy With Double Tract Reconstruction. NCT06477562 | Saint Vincent's Hospital, Korea | — |
| Completed | [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer NCT05898854 | Aalborg University Hospital | Phase 2 |
| Completed | A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients NCT06339307 | Tianjin Medical University Cancer Institute and Hospital | — |
| Recruiting | PRIORITY-CONNECT 2 Pilot Trial NCT06212700 | Surgical Outcomes Research Centre (SOuRCe) | N/A |
| Recruiting | Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors NCT06293898 | SystImmune Inc. | Phase 1 |
| Recruiting | T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma NCT05894824 | Yonsei University | Phase 1 / Phase 2 |
| Not Yet Recruiting | Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unre NCT06241469 | Wu Jun | Phase 2 |
| Recruiting | Microbiota in Gastric Cancer by Gastric Mucosal Brushing NCT06325891 | King Chulalongkorn Memorial Hospital | — |
| Unknown | Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis NCT06278064 | Beijing Friendship Hospital | — |
| Unknown | Investigating the Experiences of Individuals With Gastric Cancer Participating in Clinical Trials NCT05699278 | Power Life Sciences Inc. | — |
| Not Yet Recruiting | Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer NCT06229197 | Sichuan University | N/A |
| Unknown | Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With NCT06227325 | Henan Cancer Hospital | Phase 2 |
| Unknown | Exploratory Study of Single-port Robot-assisted Gastrectomy NCT06201585 | Hebei Medical University | N/A |
| Recruiting | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy NCT06362070 | Azienda Ospedaliera Universitaria Integrata Verona | N/A |
| Recruiting | Effect of Gastrectomy on Gut Microbiome and Cognitive Function NCT06186089 | Jiangjiang Bi | — |
| Recruiting | Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer NCT06109467 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Unknown | Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage NCT06194981 | The First Affiliated Hospital of Zhengzhou University | — |
| Unknown | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant T NCT06182644 | Guangdong Provincial People's Hospital | N/A |
| Active Not Recruiting | A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in C NCT06256328 | Ono Pharmaceutical Co., Ltd. | Phase 2 |
| Active Not Recruiting | A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and NCT06243757 | Memorial Sloan Kettering Cancer Center | — |
| Unknown | Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia NCT06123637 | Ajou University School of Medicine | N/A |
| Recruiting | Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer NCT06543108 | Hunan Cancer Hospital | — |
| Recruiting | Pilot Study for High Output Drainage Removal After Gastrectomy NCT06690112 | Gangnam Severance Hospital | N/A |
| Unknown | Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer NCT06197438 | Fujian Cancer Hospital | Phase 2 |
| Recruiting | A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique NCT06300879 | Huashan Hospital | N/A |
| Recruiting | Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer NCT06735105 | Yunnan Cancer Hospital | N/A |
| Recruiting | AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 NCT06219941 | AstraZeneca | Phase 2 |
| Completed | Impact of Robotic Surgery on Systemic Immune-inflammation Index NCT06811753 | Başakşehir Çam & Sakura City Hospital | — |
| Unknown | Association Between ABO Polymorphism and Gastric/Colorectal Cancers NCT06149923 | Assiut University | — |
| Recruiting | Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer P NCT06383559 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Completed | Appraisal of the Modified Cancer Cachexia Index in Locally Advanced Gastric Cancer Patients Undergoing Neoadju NCT06689462 | Fujian Medical University | — |
| Recruiting | Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcin NCT06155383 | RemeGen Co., Ltd. | Phase 2 |
| Unknown | Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration NCT06281860 | Dr Jean Yannis PERENTES | Phase 1 |
| Recruiting | Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients NCT05850130 | GERCOR - Multidisciplinary Oncology Cooperative Group | N/A |
| Not Yet Recruiting | NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor NCT06134960 | Peking University | Phase 1 |
| Recruiting | A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced o NCT06008054 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer NCT06102772 | Tianjin Medical University Cancer Institute and Hospital | — |
| Recruiting | Fruquintinib Combined With TAS102 for Advanced Gastric Cancer NCT06102785 | Tianjin Medical University Cancer Institute and Hospital | — |
| Recruiting | Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD- NCT06102759 | Tianjin Medical University Cancer Institute and Hospital | — |
| Unknown | The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer NCT06432205 | Peking University | — |
| Recruiting | Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malig NCT06126406 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Meta NCT06047379 | Neonc Technologies, Inc. | Phase 1 / Phase 2 |
| Unknown | Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer NCT06046846 | Queen Margaret University | N/A |
| Recruiting | A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Can NCT06485271 | Changzhi People's Hospital Affiliated to Changzhi Medical College | — |
| Unknown | Safety and Efficacy of NK510 to Treat Gastric Cancer NCT06098898 | Base Therapeutics (Shanghai) Co., Ltd. | EARLY_Phase 1 |
| Not Yet Recruiting | Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial NCT06115629 | University of Dublin, Trinity College | Phase 3 |
| Not Yet Recruiting | Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer NCT05318794 | Imperial College London | Phase 2 |
| Unknown | Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent NCT06075849 | Panolos Bioscience | Phase 1 |
| Completed | Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis NCT06109805 | Beijing Friendship Hospital | — |
| Terminated | Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinom NCT06206278 | LianBio LLC | Phase 2 |
| Unknown | A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susc NCT06100003 | Funan Liu | — |
| Recruiting | Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastr NCT06054906 | Huashan Hospital | Phase 2 |
| Recruiting | Cytosponge for Gastric Intestinal Metaplasia NCT05657080 | University of Cambridge | — |
| Unknown | Exploratory Study of Toumai Endoscopic Surgery System for Remote Gastrectomy NCT06073483 | Hebei Medical University | N/A |
| Active Not Recruiting | Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers NCT05891171 | Arcus Biosciences, Inc. | Phase 1 |
| Recruiting | Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) NCT06101277 | University of California, Davis | N/A |
| Recruiting | A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer NCT06038578 | Toray Industries, Inc | Phase 2 |
| Active Not Recruiting | A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibit NCT05867121 | Genentech, Inc. | Phase 1 |
| Not Yet Recruiting | Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer NCT06094868 | Second Affiliated Hospital of Nanchang University | Phase 2 |
| Recruiting | REVOLUTION Surgery (REVOLUTION Surgery) NCT05642819 | University of Edinburgh | — |
| Completed | ERAS for Gastric Cancer Patients After NACT NCT06365814 | The Affiliated Hospital of Qingdao University | — |
| Recruiting | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors NCT06010862 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Completed | 18F-FDG PET/CT in Gastric Cancer NCT07528131 | Sohag University | — |
| Recruiting | IKS014 in Advanced Solid Tumors That Express HER2 NCT05872295 | Iksuda Therapeutics Ltd. | Phase 1 |
| Unknown | A Multi-omics-based Metabolic Typing Study of Gastric Cancer NCT06134011 | Zhejiang Cancer Hospital | — |
| Recruiting | AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy NCT06035250 | Chinese Academy of Sciences | — |
| Recruiting | CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid NCT06006390 | Chongqing Precision Biotech Co., Ltd | Phase 1 / Phase 2 |
| Recruiting | Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing NCT06036563 | Air Force Military Medical University, China | — |